GFAP and Alzheimer disease: Apart from core plasma AD biomarkers, glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) are proteins found in the astroglia and neuronal axons respectively and, therefore, are considered biomarkers of glial activation or axonal damage [14, 15].